KLDO OTC
Kaleido Biosciences, Inc.
1W: +0.0%
1M: +0.0%
3M: +9900.0%
YTD: +0.0%
1Y: +0.0%
3Y: +900.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+13.2% ▲
Gross Profit
-$1M
+97.7% ▲
Operating Income
-$88M
-11.1% ▼
Net Income
-$90M
-10.6% ▼
EPS (Diluted)
$-2.16
+11.5% ▲
EBITDA
-$85M
-10.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $975K | $1M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +13.2% |
| Cost of Revenue | $0 | $0 | $1M | $56K | $2M |
| Gross Profit | $0 | $0 | -$1M | -$55M | -$1M |
| Gross Margin | — | — | — | -5640.2% | -113.6% |
| R&D Expenses | $21M | $42M | $64M | $56M | $68M |
| SG&A Expenses | $6M | $19M | $22M | $24M | $21M |
| Operating Expenses | $27M | $61M | $87M | $24M | $86M |
| Operating Income | -$27M | -$61M | -$87M | -$79M | -$88M |
| Operating Margin | — | — | — | -8089.6% | -7940.9% |
| Interest Expense | $435K | $1M | $977K | $3M | $3M |
| Income Before Tax | -$28M | -$62M | -$86M | -$82M | -$90M |
| Tax Expense | -$94K | -$56K | $0 | $0 | $0 |
| Net Income | -$28M | -$62M | -$85M | -$82M | -$90M |
| Net Margin | — | — | — | -8371.3% | -8178.3% |
| EPS (Diluted) | $-1.23 | $-2.10 | $-3.31 | $-2.44 | $-2.16 |
| EBITDA | -$27M | -$59M | -$84M | -$77M | -$85M |
| Shares Outstanding | 22M | 29M | 26M | 33M | 42M |